These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7609532)

  • 1. HIT, HITT, and desulfatohirudin: look before you leap.
    Edmunds LH
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):1-3. PubMed ID: 7609532
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of recombinant hirudin in patients with heparin-induced thrombocytopenia with thrombosis requiring cardiopulmonary bypass.
    Latham P; Revelis AF; Joshi GP; DiMaio JM; Jessen ME
    Anesthesiology; 2000 Jan; 92(1):263-6. PubMed ID: 10638925
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulation for patients with heparin-induced thrombocytopenia using recombinant hirudin during cardiopulmonary bypass.
    Liu H; Fleming NW; Moore PG
    J Clin Anesth; 2002 Sep; 14(6):452-5. PubMed ID: 12393116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of ecarin clotting time in whole blood for monitoring recombinant hirudine treatment during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia].
    Devignes J; de Maistre E; Grosjean S; Walter AF; Hacquard M; Mulot A; Longrois D; Carteaux JP; Lecompte T
    Ann Biol Clin (Paris); 2005; 63(2):201-8. PubMed ID: 15771978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin induced thrombocytopenia thrombosis (HIT/T) syndrome: diagnosis and treatment.
    Baglin TP
    J Clin Pathol; 2001 Apr; 54(4):272-4. PubMed ID: 11304842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of recombinant hirudin in heparin-induced thrombocytopenia and thrombosis (HITT) and renal failure--a case report.
    Whelen S; Carr ME
    Angiology; 2001 Oct; 52(10):711-5. PubMed ID: 11666136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant desulfatohirudin as a substitute for heparin during cardiopulmonary bypass.
    Bernabei A; Rao AK; Niewiarowski S; Colman RW; Sun L; Edmunds LH
    J Thorac Cardiovasc Surg; 1994 Aug; 108(2):381-2. PubMed ID: 8041187
    [No Abstract]   [Full Text] [Related]  

  • 8. Image of the month. Heparin-induced thrombocytopenia: stop all heparin therapy and treat with lepirudin.
    Bush RL; Lin PH; Lumsden AB
    Arch Surg; 2002 Feb; 137(2):221-2. PubMed ID: 11822964
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapy for patients with heparin-induced thrombocytopenia marketed.
    Am J Health Syst Pharm; 1998 Jul; 55(14):1444. PubMed ID: 9676284
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anticoagulation after venous thrombosis caused by type-II HIT syndrome].
    Janssens U
    Dtsch Med Wochenschr; 1998 Apr; 123(14):438-9. PubMed ID: 9581173
    [No Abstract]   [Full Text] [Related]  

  • 11. Alternative methods of anticoagulation for dialysis-dependent patients with heparin-induced thrombocytopenia.
    O'Shea SI; Ortel TL; Kovalik EC
    Semin Dial; 2003; 16(1):61-7. PubMed ID: 12535303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hirudin therapy during thrombolysis for venous thrombosis in heparin-induced thrombocytopenia.
    Reilly MP; Weiss R; Askenase A; Tuite C; Soulen M; Mohler ER
    Vasc Med; 2000; 5(4):239-42. PubMed ID: 11213236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant hirudin in clinical practice: focus on lepirudin.
    Greinacher A; Lubenow N
    Circulation; 2001 Mar; 103(10):1479-84. PubMed ID: 11245656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulant monitoring techniques in a heparin-induced thrombocytopenia patient undergoing cardiopulmonary bypass using bivalirudin anticoagulant.
    Baker T; Chan R; Hill F
    J Extra Corpor Technol; 2004 Dec; 36(4):371-4. PubMed ID: 15679282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-induced thrombocytopenia: a ten-year retrospective.
    Warkentin TE
    Annu Rev Med; 1999; 50():129-47. PubMed ID: 10073268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hirulog therapy for heparin-associated thrombocytopenia and deep venous thrombosis.
    Reid T; Alving BM
    Am J Hematol; 1994 Apr; 45(4):352-3. PubMed ID: 8192819
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of ecarin clotting time (ECT) with lepirudin therapy in heparin-induced thrombocytopenia and cardiopulmonary bypass.
    Fabrizio MC
    J Extra Corpor Technol; 2001 May; 33(2):117-25. PubMed ID: 11467439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with a history of type II heparin-induced thrombocytopenia with thrombosis requiring cardiac surgery with cardiopulmonary bypass: a prospective observational case series.
    Nuttall GA; Oliver WC; Santrach PJ; McBane RD; Erpelding DB; Marver CL; Zehr KJ
    Anesth Analg; 2003 Feb; 96(2):344-50, table of contents. PubMed ID: 12538175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is thrombin a pharmacological target during reperfusion?
    White HD
    Blood Coagul Fibrinolysis; 1999 Feb; 10 Suppl 1():S55-7. PubMed ID: 10070820
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of heparin induced thrombocytopenia and thrombosis during the first trimester of pregnancy.
    Mehta R; Golichowski A
    J Thromb Haemost; 2004 Sep; 2(9):1665-6. PubMed ID: 15333046
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.